Metritrack,Inc
Hillside, US · Founded 2014 · Delaware corporation
Biotech
Founders & leadership
CC
Calin CaluserExecutive Officer, Director, Promoter
JK
Jonathan KaufmanExecutive Officer, Director
DM
David McClellanDirector
Reported raises · per SEC filings
Form D private placements▶$1.5MraisedMar 2019 · 4 investors · ManufacturingRule 506(b)
▶$1.5MraisedMar 2019 · 4 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Calin CaluserExecutive Officer, Director
- Michael CannizzaroDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$325KraisedOct 2018 · 1 investors · BiotechnologyRule 506(b)
▶$325KraisedOct 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mario DonatoDirector
- Mike CannizzaroDirector
- Calin CaluserDirector
- Offering amount
- $325K
- Amount sold
- $325K
- Minimum investment
- $325K
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$325KraisedSep 2018 · 1 investors · BiotechnologyRule 506(c)
▶$325KraisedSep 2018 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Calin ClauserExecutive Officer, Director
- Offering amount
- $325K
- Amount sold
- $325K
- Minimum investment
- $325K
- Proceeds to insiders
- $3.3M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$222.3KraisedAug 2016 · 1 investors · BiotechnologyRule 506(b)
▶$222.3KraisedAug 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael N. CannizzaroDirector
- Calin CaluserExecutive Officer, Director, Promoter
- David McClellanDirector
- Jonathan KaufmanExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $222.3K
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$46KofferedApr 2015 · BiotechnologyRule 506(b)
▶$46KofferedApr 2015 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan KaufmanExecutive Officer, Director
- David McClellanDirector
- Calin CaluserExecutive Officer, Director, Promoter
- Offering amount
- $46K
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$100KraisedFeb 2015 · 1 investors · BiotechnologyRule 506(b)
▶$100KraisedFeb 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan KaufmanExecutive Officer, Director
- Calin CaluserExecutive Officer, Director, Promoter
- David McClellanDirector
- Offering amount
- $450K
- Amount sold
- $100K
- Minimum investment
- $10K
- Proceeds to insiders
- $20K
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $205.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.